Collectively, our findings thus demonstrate that the inhibition of IRE1 kinase activity by a small‐molecule inhibitor or genetic ablation of FMRP, its kinase substrate, in macrophages can reduce the progression of hypercholesterolemia‐induced atherosclerosis. This evidence concerns the gene FMR1 and Hypercholesterolemia.